Document is current
Any future updates will be listed below
-
Authors
Birg, Tatiana
Ortolano, Fabrizio
Wiegers, Eveline J. A.
Smielewski, Peter
Savchenko, Yan
Ianosi, Bogdan A.
Helbok, Raimund
Rossi, Sandra
Carbonara, Marco
Zoerle, Tommaso
Stocchetti, Nino https://orcid.org/0000-0003-3250-6834
,
Anke, Audny
Beer, Ronny
Bellander, Bo-Michael
Beqiri, Erta
Buki, Andras
Cabeleira, Manuel
Chieregato, Arturo
Citerio, Giuseppe
Clusmann, Hans
Czeiter, Endre
Czosnyka, Marek
Depreitere, Bart
Ercole, Ari
Frisvold, Shirin
Jankowski, Stefan
Kondziella, Danile
Koskinen, Lars-Owe
Kowark, Ana
Menon, David K.
Meyfroidt, Geert
Moeller, Kirsten
Nelson, David
Piippo-Karjalainen, Anna
Radoi, Andreea
Ragauskas, Arminas
Raj, Rahul
Rhodes, Jonathan
Rocka, Saulius
Rossaint, Rolf
Sahuquillo, Juan
Sakowitz, Oliver
Sundström, Nina
Takala, Riikka
Tamosuitis, Tomas
Tenovuo, Olli
Vajkoczy, Peter
Vargiolu, Alessia
Vilcinis, Rimantas
Wolf, Stefan
Younsi, Alexander
Zeiler, Frederick A.
-
Funding
Funding for this research was provided by:
FP7 Health (602150)
Università degli Studi di Milano
- License Information
-
More Information
Article History
Received: 6 November 2020
Accepted: 9 June 2021
First Online: 30 July 2021
Declarations
:
: Dr. Birg reports grants from the European Commission 7th Framework program (602150), grants from the Hannelore Kohl Stiftung (Germany), grants from OneMind (USA), grants from Integra LifeSciences Corporation (USA), and grants from Neurotrauma Sciences (USA) during the conduct of the study. Dr. Ortolano reports grants from the European Commission 7th Framework program (602150), grants from the Hannelore Kohl Stiftung (Germany), grants from OneMind (USA), grants from Integra LifeSciences Corporation (USA), and grants from Neurotrauma Sciences (USA) during the conduct of the study. Dr. Wiegers reports grants from the European Commission 7th Framework program (602150), grants from the Hannelore Kohl Stiftung (Germany), grants from OneMind (USA), grants from Integra LifeSciences Corporation (USA), and grants from Neurotrauma Sciences (USA) during the conduct of the study. Dr. Smielewski reports grants from the European Commission 7th Framework program (602150) during the conduct of the study; personal fees from Cambridge Enterprise Ltd, Cambridge, UK, outside the submitted work. Dr. Savchenko reports grants from the European Commission 7th Framework program (602150), grants from the Hannelore Kohl Stiftung (Germany), grants from OneMind (USA), grants from Integra LifeSciences Corporation (USA), and grants from Neurotrauma Sciences (USA) during the conduct of the study. Dr. Ianosi reports grants from the European Commission 7th Framework program (602150), grants from the Hannelore Kohl Stiftung (Germany), grants from OneMind (USA), grants from Integra LifeSciences Corporation (USA), grants from Neurotrauma Sciences (USA), during the conduct of the study. Dr. Helbok reports grants from the European Commission 7th Framework program (602150), grants from the Hannelore Kohl Stiftung (Germany), grants from OneMind (USA), grants from Integra LifeSciences Corporation (USA), grants from Neurotrauma Sciences (USA), during the conduct of the study. Dr. Rossi reports grants from the European Commission 7th Framework program (602150), grants from the Hannelore Kohl Stiftung (Germany), grants from OneMind (USA), grants from Integra LifeSciences Corporation (USA), grants from Neurotrauma Sciences (USA), during the conduct of the study. Dr. Carbonara reports grants from the European Commission 7th Framework program (602150), grants from the Hannelore Kohl Stiftung (Germany), grants from OneMind (USA), grants from Integra LifeSciences Corporation (USA), grants from Neurotrauma Sciences (USA), during the conduct of the study. Dr. Zoerle reports grants from the European Commission 7th Framework program (602150), grants from the Hannelore Kohl Stiftung (Germany), grants from OneMind (USA), grants from Integra LifeSciences Corporation (USA), grants from Neurotrauma Sciences (USA), during the conduct of the study. Dr. Stochetti reports grants from the European Commission 7th Framework program (602150), grants from the Hannelore Kohl Stiftung (Germany), grants from OneMind (USA), grants from Integra LifeSciences Corporation (USA), grants from Neurotrauma Sciences (USA), during the conduct of the study.
: In each recruiting site ethical approval was given; an overview is available online [].
: ClinicalTrials.gov: NCT02210221.
